UNI-EN 65:Notification
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 65 | / | 2015 | | ||||||
| Date of issue: | 2015-07-09 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Notification | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| The Board of Directors of SOPHARMA AD (the “Company") hereby informs of the results of the tender offering for the shares of Momina Krepost AD, published in two national newspapers: Capital Daily and Sega on 1 July 2015. In connection with the requirements of art. 37, par. 1 of Ordinance №13 for tender offers for the purchase and exchange of shares, Sopharma AD as a tender offeror, who has made a tender offering under art. 149, par. 6 of POSA to purchase all shares of other shareholders of Momina Krepost AD, informs on the following results of the tender offering: - shareholders who have accepted the tender offering: 38 shareholders with a total number of shares: 211 991, - as a result of the conducted tender offering and after completion of the transactions with shares of shareholders who have accepted it, Sopharma AD now holds directly 92.62% of the shares from the capital of Momina Krepost AD. Please, give publicity to the present information | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| uved za targovo_MKR_2015 ENG.doc uved za targovo_MKR_2015 ENG.doc | Notification | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2015-07-09 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 7.09 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
